Vast Therapeutics
Dr. Donaldson currently serves as the Medical Director for UNC Pulmonary Clinics; Associate Director, UNC Clinical and Translational Research Center and Director, UNC-Chapel Hill Adult CF Care Center. His clinical and research interests are focused on adults with cystic fibrosis (CF). Over the past two decades, he has been involved in the development of several potential new therapies that improve mucus clearance from the lung in CF.
This person is not in the org chart
This person is not in any offices
Vast Therapeutics
Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.